Vaccine Therapy for Patients With Stage III Melanoma
Clinical trial NCT00052130 · UNKNOWN
Trial details
- NCT number
- NCT00052130
- Sponsor
- CancerVax Corporation
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 1118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.